Is there treatment against novel H1N1 flu for people with HIV/AIDS?
Yes. The novel H1N1 flu virus is sensitive to two antiviral drugs: zanamivir and oseltamivir. HIV-infected adults and adolescents who meet current case-definitions for confirmed, probable or suspected infection with novel H1N1 flu should receive antiviral treatment. Treatment is most effective if started within 48 hours of symptom onset. Please check the CDC website frequently for updates in recommendations for antiviral treatment. See additional information on treatment of novel H1N1 flu. When should people with HIV/AIDS be prescribed antiviral medications for the prevention (also called “chemoprophylaxis”) of novel H1N1 flu? HIV-infected adults and adolescents who are close contacts of persons with novel H1N1 flu should receive antiviral chemoprophylaxis. Please check the CDC website frequently for updates in recommendations for antiviral chemoprophylaxis. Are the medicines used to treat and prevent infection with the novel H1N1 flu virus safe for people with HIV/AIDS? There is not a
